Effects of Two Commonly Found Strains of Influenza A Virus on Developing Dopaminergic Neurons, in Relation to the Pathophysiology of Schizophrenia

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Landreau, Fernando ^a   Galeano, Pablo ^b   Caltana, Laura R ^b   Masciotra, Luis ^b   Chertcoff, Agustín ^c   Pontoriero, A ^a   Baumeister, Elsa ^a   Amoroso, Marcela ^a,b   Brusco, Herminia A ^c   Tous, Mónica I ^a   Savy, Vilma L ^a   Lores Arnaiz, María del Rosario ^a,b   de Erausquin, Gabriel A ^d  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; BINDING AFFINITY; BRAIN DEVELOPMENT; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INTRAUTERINE INFECTION; MESENCEPHALON; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROGENY; SCHIZOPHRENIA; VIRUS ISOLATION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MAZE LEARNING; MICE; ORTHOMYXOVIRIDAE INFECTIONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84870946904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051068     Document Type: Article

References (84)

1. Mednick SA, Machon RA, Huttunen MO, (1990) An update on the Helsinki Influenza Project. Arch. Gen. Psychiatry 47: 292.
2. O'Callaghan E, Sham P, Takei N, Glover G, Murray RM, (1991) Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 337: 1248-1250.
3. Adams W, Kendell RE, Hare EH, Munk-Jørgensen P, (1993) Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br J Psychiatry 163: 522-534.
4. Izumoto Y, Inoue S, Yasuda N, (1999) Schizophrenia and the influenza epidemics of 1957 in Japan. Biol. Psychiatry 46: 119-124.
5. Brown AS, Derkits EJ, (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167: 261-280 doi:10.1176/appi.ajp.2009.09030361.
6. Munk-Jørgensen P, Ewald H (2001) Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia theory. Br J Psychiatry Suppl 40: s30-32.
7. Takei N, Murray RM, Sham P, O'Callaghan E, (1995) Schizophrenia risk for women from in utero exposure to influenza. Am J Psychiatry 152: 150-151.
8. Dassa D, Takei N, Sham PC, Murray RM, (1995) No association between prenatal exposure to influenza and autism. Acta Psychiatr Scand 92: 145-149.
9. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS, (2005) Autistic disorder and viral infections. J. Neurovirol 11: 1-10 doi:10.1080/13550280590900553.
10. Shi L, Fatemi SH, Sidwell RW, Patterson PH, (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci 23: 297-302.
11. Crow TJ, (1992) Maternal viral infection hypothesis. Br J Psychiatry 161: 570-572.
12. Morgan V, Castle D, Page A, Fazio S, Gurrin L, et al. (1997) Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect. Schizophr. Res 26: 25-39 doi:10.1016/S0920-9964(97)00033-9.
13. Selten JP, Brown AS, Moons KG, Slaets JP, Susser ES, et al. (1999) Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands. Schizophr. Res 38: 85-91.
14. Mino Y, Oshima I, Tsuda T, Okagami K, (2000) No relationship between schizophrenic birth and influenza epidemics in Japan. J Psychiatr Res 34: 133-138.
15. Cotter D, Takei N, Farrell M, Sham P, Quinn P, et al. (1995) Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus? Schizophr. Res 16: 233-241.
16. Fatemi SH, Sidwell R, Akhter P, Sedgewick J, Thuras P, et al. (1998) AID-SYN8>3.0.CO; 2-7.
17. Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, et al. (1999) Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry 4: 145-154.
18. Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P, (2000) Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11: 1493-1496.
19. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, et al. (2002) Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol 22: 25-33.
20. Laing P, Knight JG, Hill JM, Harris AG, Oxford JS, et al. (1989) Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. Proc. Natl. Acad. Sci. U.S.A 86: 1998-2002.
21. Zuckerman L, Weiner I, (2005) Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39: 311-323 doi:10.1016/j.jpsychires.2004.08.008.
22. Zuckerman L, Rehavi M, Nachman R, Weiner I, (2003) Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28: 1778-1789 doi:10.1038/sj.npp.1300248.
23. Aronsson F, Lannebo C, Paucar M, Brask J, Kristensson K, et al. (2002) Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy. J. Neurovirol 8: 353-357 doi:10.1080/13550280290100480.
24. Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, et al. (1995) The substantia nigra is a major target for neurovirulent influenza A virus. J. Exp. Med 181: 2161-2169.
25. Takahashi M, Yamada T, (2001) A possible role of influenza A virus infection for Parkinson's disease. Adv Neurol 86: 91-104.
26. Takahashi M, Yamada T, Nakanishi K, Fujita K, Nakajima K, et al. (1997) Influenza a virus infection of primary cultured cells from rat fetal brain. Parkinsonism Relat. Disord 3: 97-102.
27. Mori I, Kimura Y, (2000) Apoptotic neurodegeneration induced by influenza A virus infection in the mouse brain. Microbes Infect 2: 1329-1334.
28. Mori I, Imai Y, Kohsaka S, Kimura Y, (2000) Upregulated expression of Iba1 molecules in the central nervous system of mice in response to neurovirulent influenza A virus infection. Microbiol. Immunol 44: 729-735.
29. Goto H, Wells K, Takada A, Kawaoka Y, (2001) Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. J. Virol 75: 9297-9301 doi:10.1128/JVI.75.19.9297-9301.2001.
30. Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM, et al. (2004) Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124: 619-628 doi:10.1016/j.neuroscience.2003.12.017.
31. Chakos MH, Mayerhoff DI, Loebel AD, Alvir JM, Lieberman JA, (1992) Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacol Bull 28: 81-86.
32. Caligiuri MP, Lohr JB, Jeste DV, (1993) Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry 150: 1343-1348.
33. Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, et al. (1995) Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 152: 1724-1729.
34. Wolff AL, O'Driscoll GA, (1999) Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci 24: 304-314.
35. Honer WG, Kopala LC, Rabinowitz J, (2005) Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. J. Psychopharmacol. (Oxford) 19: 277-285 doi:10.1177/0269881105051539.
36. Bogerts B, Häntsch J, Herzer M, (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol. Psychiatry 18: 951-969.
37. Kolomeets NS, Uranova NA, (1999) Synaptic contacts in schizophrenia: studies using immunocytochemical identification of dopaminergic neurons. Neurosci. Behav. Physiol 29: 217-221.
38. Benes FM, Todtenkopf MS, Taylor JB (1997) AID-SYN10>3.0.CO;2-2.
39. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, et al. (1999) Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156: 1580-1589.
40. Albert KA, Hemmings HC, Adamo AIB, Potkin SG, Akbarian S, et al. (2002) Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 59: 705-712.
41. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A 98: 6917-6922 doi:10.1073/pnas.111134598.
42. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, et al. (2004) New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161: 1110-1112.
43. Masciotra L, Landreau F, Conesa HA, de Erausquin GA (2005) Pathophysiology of schizophrenia: a new look at the role of dopamine. Trends in schizophrenia research. New York: Nova Biomedical Books. 27-44.
44. Carter CJ, Pycock CJ, (1980) Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res 192: 163-176.
45. Weinberger DR, (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44: 660-669.
46. Grilli M, Wright AG, Hanbauer I, (1991) Characterization of [3H]dopamine uptake sites and [3H]cocaine recognition sites in primary cultures of mesencephalic neurons during in vitro development. J. Neurochem 56: 2108-2115.
47. de Erausquin G, Brooker G, Hanbauer I, (1992) K(+)-evoked dopamine release depends on a cytosolic Ca2+ pool regulated by N-type Ca2+ channels. Neurosci. Lett 145: 121-125.
48. de Erausquin G, Brooker G, Costa E, Hanbauer I, (1994) Persistent AMPA receptor stimulation alters [Ca2+]i homeostasis in cultures of embryonic dopaminergic neurons. Brain Res. Mol. Brain Res 21: 303-311.
49. Valchár M, Hanbauer I, (1995) Rat mesencephalic neuronal cells cultured for different periods as a model of dopamine transporter ontogenesis. Mol. Neurobiol 11: 111-119 doi:10.1007/BF02740689.
50. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am. J. Hygiene 27: 493-497.
51. de Erausquin GA, Hyrc K, Dorsey DA, Mamah D, Dokucu M, et al. (2003) Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons. Mol. Pharmacol 63: 784-790.
52. Anastasia A, de Erausquin GA, Wojnacki J, Mascó DH, (2007) Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease. J. Neurochem 103: 1542-1552 doi:10.1111/j.1471-4159.2007.04856.x.
53. Anastasía A, Torre L, de Erausquin GA, Mascó DH, (2009) Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease. J. Neurochem 109: 755-765 doi:10.1111/j.1471-4159.2009.06001.x.
54. Ludwig S, Planz O, (2008) Influenza viruses and the NF-kappaB signaling pathway- towards a novel concept of antiviral therapy. Biol. Chem 389: 1307-1312 doi:10.1515/BC.2008.148.
55. Fruntes V, Limosin F, (2008) Schizophrenia and viral infection during neurodevelopment: a pathogenesis model? Med. Sci. Monit 14: RA71-77.
56. Sperner-Unterweger B, (2005) Biological hypotheses of schizophrenia: possible influences of immunology and endocrinology. Fortschr Neurol Psychiatr 73 (Suppl 1): S38-43 doi:10.1055/s-2005-915544.
57. Carter CJ, (2009) Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull 35: 1163-1182 doi:10.1093/schbul/sbn054.
58. Dale RC, Church AJ, Surtees RAH, Lees AJ, Adcock JE, et al. (2004) Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 127: 21-33 doi:10.1093/brain/awh008.
59. Takahashi M, Yamada T, (1999) Viral etiology for Parkinson's disease-a possible role of influenza A virus infection. Jpn. J. Infect. Dis 52: 89-98.
60. Le TQ, Kawachi M, Yamada H, Shiota M, Okumura Y, et al. (2006) Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain. Biol. Chem 387: 467-475 doi:10.1515/BC.2006.062.
61. Brask J, Chauhan A, Hill RH, Ljunggren H, Kristensson K, (2005) Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins. J. Neurovirol 11: 395-402 doi:10.1080/13550280500186916.
62. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, et al. (2008) Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J. Immunol 180: 3391-3398.
63. Smidt MP, van Schaick HS, Lanctôt C, Tremblay JJ, Cox JJ, et al. (1997) A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A 94: 13305-13310.
64. Yamada T, (1996) Viral etiology of Parkinson's disease: Focus on influenza A virus. Parkinsonism Relat. Disord 2: 113-121.
65. Nakajima K, (1997) [Neurovirulence of influenza virus in mice]. Nippon Rinsho 55: 2693-2698.
66. Mori I, Diehl AD, Chauhan A, Ljunggren HG, Kristensson K, (1999) Selective targeting of habenular, thalamic midline and monoaminergic brainstem neurons by neurotropic influenza A virus in mice. J. Neurovirol 5: 355-362.
67. Mori I, Goshima F, Imai Y, Kohsaka S, Sugiyama T, et al. (2002) Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis. J. Gen. Virol 83: 2109-2116.
68. Mori I, Liu B, Hossain MJ, Takakuwa H, Daikoku T, et al. (2002) Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice. Virology 303: 287-296.
69. Mori I, Goshima F, Koshizuka T, Koide N, Sugiyama T, et al. (2003) Differential activation of the c-Jun N-terminal kinase/stress-activated protein kinase and p38 mitogen-activated protein kinase signal transduction pathways in the mouse brain upon infection with neurovirulent influenza A virus. J. Gen. Virol 84: 2401-2408.
70. Mori I, Kimura Y, (2001) Neuropathogenesis of influenza virus infection in mice. Microbes Infect 3: 475-479.
71. Leyva-Grado VH, Churchill L, Wu M, Williams TJ, Taishi P, et al. (2009) Influenza virus- and cytokine-immunoreactive cells in the murine olfactory and central autonomic nervous systems before and after illness onset. J. Neuroimmunol 211: 73-83 doi:10.1016/j.jneuroim.2009.03.016.
72. Kimura Y, (2000) Pathophysiological events in the central nervous system of mice during neurovirulent influenza A virus infection. Nippon Rinsho 58: 2211-2216.
73. Aronsson F, Karlsson H, Ljunggren HG, Kristensson K, (2001) Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice. J. Neurovirol 7: 117-124.
74. Aronsson F, Robertson B, Ljunggren H, Kristensson K, (2003) Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 16: 415-423 doi:10.1089/088282403322396208.
75. Beraki S, Aronsson F, Karlsson H, Ogren SO, Kristensson K, (2005) Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol. Psychiatry 10: 299-308 doi:10.1038/sj.mp.4001545.
76. Chen L, Duricka D, Nelson S, Mukherjee S, Bohnet SG, et al. (2004) Influenza virus-induced sleep responses in mice with targeted disruptions in neuronal or inducible nitric oxide synthases. J. Appl. Physiol 97: 17-28 doi:10.1152/japplphysiol.01355.2003.
77. Asp L, Beraki S, Aronsson F, Rosvall L, Ogren SO, et al. (2005) Gene expression changes in brains of mice exposed to a maternal virus infection. Neuroreport 16: 1111-1115.
78. Yamada T, Yamanaka I, Takahashi M, Nakajima S, (1996) Invasion of brain by neurovirulent influenza A virus after intranasal inoculation. Parkinsonism Relat. Disord 2: 187-193.
79. Kawashima H, Morishima T, Togashi T, Yokota S, Yamanaka G, et al. (2004) Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of influenza-associated encephalopathy of children. Neurochem. Res 29: 1537-1540.
80. Holtze M, Asp L, Schwieler L, Engberg G, Karlsson H, (2008) Induction of the kynurenine pathway by neurotropic influenza A virus infection. J. Neurosci. Res 86: 3674-3683 doi:10.1002/jnr.21799.
81. Yuede CM, Wozniak DF, Creeley CE, Taylor GT, Olney JW, et al. (2010) Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain. PLoS ONE 5: e11374 doi:10.1371/journal.pone.0011374.
82. Rubin S, Liu D, Pletnikov M, McCullers J, Ye Z, et al. (2004) Wild-type and attenuated influenza virus infection of the neonatal rat brain. J. Neurovirol 10: 305-314 doi:10.1080/13550280490499579.
83. Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, et al. (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord 17: 116-124.
84. Carvey PM, Chang Q, Lipton JW, Ling Z, (2003) Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front. Biosci 8: s826-837.